Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (22 ops.)
Latest filing published 14 May 2026 for Apellis Pharmaceuticals, Inc.. Read the official filing
Filing timeline
BuySaleDavid O. Watson
Insider track record
Disclosed buys
0
Disclosed sells
22
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
David O. Watson: trading record in brief
David O. Watson (senior executive) discloses dealings in Apellis Pharmaceuticals, Inc. to SEC (Form 4). Over a trading history stretching from 28 May 2021 to 14 May 2026, the count stands at 47 filings.
Every open-market trade on record is a sale: 22 sales worth €3.4M. Besides market trades, the filings include 12 share grants and 7 option exercises. So far in 2026, the count stands at no purchases and 3 sales.
The newest entry dates from 14 May 2026: a transaction, in Apellis Pharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to David O. Watson
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations47 total
144,517 sharesCommon StockSEC:0001193125-26-224583:0
55,986 shares0Common StockSEC:0001492422-26-000072:0
7,832 shares@ US$21.76544.7% of flowCommon StockSEC:0001492422-26-000054:0
2,475 shares@ US$19.79291.4% of flowCommon StockSEC:0001492422-26-000038:0
5,780 shares@ US$22.18723.5% of flowCommon StockSEC:0001492422-26-000025:0
888 shares@ US$14.950.4% of flowCommon StockSEC:0001492422-26-000017:0
5,000 shares@ US$24.493.7% of flowCommon StockSEC:0001492422-25-000014:0
5,000 shares@ US$20.064.2% of flowCommon StockSEC:0001492422-25-000012:0
5,000 shares@ US$25.224.0% of flowCommon StockSEC:0001492422-25-000009:0
5,000 shares@ US$24.344.0% of flowCommon StockSEC:0001492422-25-000007:0
20,000 shares@ US$26.1718.0% of flowCommon StockSEC:0001193125-25-202168:0
5,000 shares@ US$27.805.8% of flowCommon StockSEC:0001127602-25-020714:0
5,000 shares@ US$19.5511.2% of flowCommon StockSEC:0001127602-25-019411:0
5,000 shares@ US$18.7712.2% of flowCommon StockSEC:0001127602-25-017714:0
6,667 shares0Common StockSEC:0000950170-25-034908:0
695 shares@ US$29.52361.0% of flowCommon StockSEC:0001127602-25-002389:0
3,323 shares@ US$30.42554.8% of flowCommon StockSEC:0001127602-25-001847:0
2,201 shares@ US$29.95823.1% of flowCommon StockSEC:0001127602-25-001631:0
42,762 shares0Common StockSEC:0001127602-25-001631:1
4,965 shares@ US$28.70216.8% of flowCommon StockSEC:0001127602-25-001204:0
5,000 shares@ US$34.2358.0% of flowCommon StockSEC:0000950170-24-136202:0
10,569 shares0Common StockSEC:0000950170-24-110373:0
3,762 shares@ US$13.852.4% of flowCommon StockSEC:0001127602-24-009113:0
781 shares@ US$67.76692.4% of flowCommon StockSEC:0001127602-24-004737:0
906 shares@ US$64.13822.6% of flowCommon StockSEC:0001127602-24-002755:0
25 of 47 declarations
